Division of Nephrology and Hypertension Archive — Page 7 of 9

Smiling older couple seated together indoors as the man kisses the woman on the cheek.
March 15, 2018

Research explores barriers to kidney disease screening

New research by Vanderbilt nephrologists highlights potential barriers that may prevent black Americans from being screened for kidney disease.

October 13, 2017

New tools to combat kidney fibrosis

Vanderbilt investigators have developed a new mouse model of kidney fibrosis, which provides a platform for identifying new targets and treatment strategies.

September 28, 2017

Major grant to enhance kidney disease research

Vanderbilt’s Division of Nephrology and Hypertension has received a five-year, $5 million federal grant to provide core research services in the fight against kidney disease.

September 11, 2017

Vanderbilt, Bayer collaborate to develop new therapies against kidney diseases

Vanderbilt University Medical Center (VUMC) and Bayer have agreed on a five-year strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases, with the goal of accelerating the translation of innovative approaches from the laboratory to pre-clinical development.

A smiling man reclines in a dialysis chair beside a dialysis machine, with tubing connected to his arm.
August 31, 2017

End-stage kidney disease study seeks to delay dialysis

Vanderbilt University Medical Center (VUMC) is studying the safety of a possible treatment for diabetic kidney disease that would delay or prevent the need for kidney replacement such as dialysis.

Insulin in vials
May 11, 2017

EETs contribute to insulin sensitivity

Interventions that increase circulating levels of compounds called EETs may improve insulin sensitivity and treat hypertension.